[Pre-Aug 2018] IMSCAR
- Web publication/site › Research
- Published
Improving Outcomes for People with Sarcoma - Analysis of Potential Economic Impact.
Linck, P. G., Linck, P., Hughes, D. A. & Edwards, R. T., 22 Mar 2006Research output: Non-textual form › Web publication/site
- Published
Improving Outcomes in Children and Young People with Cancer: Analysis of the Potential Economic Impact of the Guidance.
Linck, P. G., Linck, P., Tunnage, B., Hughes, D. A. & Edwards, R. T., 24 Aug 2005Research output: Non-textual form › Web publication/site
- Published
Investigating factors influencing user choices to visit either general practitioners or community pharmacists in the management of minor ailments – piloting a discrete choice experiment
Hughes, D., Hughes, D. A., Myles, S., Longo, M. & Lisles, C., 1 Mar 2008Research output: Non-textual form › Web publication/site
- Working paper › Research
- Published
Measuring Later Life Social Exclusion in Understanding Society
MacLeod, C., Ross, A., Windle, G., Netuveli, G. & Sacker, A., 27 Jun 2016, The International Centre for Lifecourse Studies in Society and Health (ICLS): University College London, p. 1-14, 14 p.Research output: Working paper
- Other report › Research › Not peer-reviewed
- Published
The evaluation of the National Exercise Referral Scheme in Wales
Murphy, S. M., Raisanen, L., Moore, G., Edwards, R., Linck, P., Hounsome, N., Williams, N., Din, N. & Moore, L., 2010, Welsh Government. (Social research; no. Number: 07/2010)Research output: Book/Report › Other report
- Commissioned report › Research › Peer-reviewed
- Published
Byw yn dda yn hirach: Y ddadl economaidd dros fuddsoddi yn iechyd a llesiant pobl hŷn yng Nghymru
Edwards, R., Spencer, L., Bryning, L. & Anthony, B., 30 Jul 2018, 68 p.Research output: Book/Report › Commissioned report › peer-review
- Published
Living Well for Longer: Economic argument investing in the health and wellbeing of older people in Wales
Edwards, R., Spencer, L., Bryning, L. & Anthony, B., 30 Jul 2018, 68 p.Research output: Book/Report › Commissioned report › peer-review
- Published
Lles mewn gwaith: Y dadleuon economaidd dros fuddsoddi mewn iechyd a lles y gweithlu yng Nghymru
Edwards, R. T., Spencer, L., Anthony, B. & Bryning, L., 17 Oct 2019, Bangor : Bangor University. 64 p.Research output: Book/Report › Commissioned report › peer-review
- Published
Transforming Young Lives across Wales: The Economic Argument for Investing in Early Years
Edwards, R., Bryning, L. & Lloyd Williams, H., 13 Oct 2016, Prifysgol Bangor University. 110 p.Research output: Book/Report › Commissioned report › peer-review
- Published
Wellness in work: The economic arguments for investing in the health and wellbeing of the workforce in Wales
Edwards, R. T., Spencer, L., Anthony, B. & Bryning, L., 17 Oct 2019, Bangor: Bangor University. 64 p.Research output: Book/Report › Commissioned report › peer-review
- Commissioned report › Research › Not peer-reviewed
- Published
A pilot clinical trial looking at the effect on lung cancer diagnosis of giving a chest X-Ray to smokers aged over 60 with chest symptoms: National Awareness and Early Diagnosis Initiative (NAEDI) Research Call Funding Partners Report
Neal, R., Edwards, R., Yeo, S. T., Hurt, C. & The ELCID Team, Aug 2015Research output: Book/Report › Commissioned report
- Published
A review of economic models for second-line chemotherapy in the management of advanced, metastatic breast cancer.
Hughes, D. & Hughes, D. A., 1 Jan 2001, 2001 ed. Unknown.Research output: Book/Report › Commissioned report
- Published
A study of the effects of the Carers Strategy in Wales on the needs of carers and the services they receive
Seddon, D., Robinson, C. A., Russell, I. T., Woods, R. T., Tommis, Y., Reeves, C., Perry, J. K. & Boyle, M., 1 Jan 2007, 2007 ed. Unknown.Research output: Book/Report › Commissioned report
- Published
AWMSG criteria for appraising new medicines.
Hughes, D. & Hughes, D. A., 1 Jan 2007, 2007 ed. Unknown.Research output: Book/Report › Commissioned report
- Published
All Wales Medicines Strategy Group Final Appraisal Report - Abacavir 600mg/lamivudine 300mg (Kivexa) in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus infection in adults and adolescents from 12 years of age.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.Research output: Book/Report › Commissioned report
- Published
All Wales Medicines Strategy Group Final Appraisal Report - Alemtuzumab (MabCampath) for the treatment of patients with B-cell chronic lymphocytic leukaemia for whom fludarabine combination chemotherapy is not appropriate.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.Research output: Book/Report › Commissioned report
- Published
All Wales Medicines Strategy Group Final Appraisal Report - Ambrisentan (Volibris) for pulmonary arterial hypertension.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2009, 2009 ed. Unknown.Research output: Book/Report › Commissioned report
- Published
All Wales Medicines Strategy Group Final Appraisal Report - Anidulafungin (Ecalta) for the treatment of invasive candidiasis in adult non-neutropenic patients.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2009, 2009 ed. Unknown.Research output: Book/Report › Commissioned report
- Published
All Wales Medicines Strategy Group Final Appraisal Report - Atazanavir (Reyataz) in treatment-experienced patients.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.Research output: Book/Report › Commissioned report
- Published
All Wales Medicines Strategy Group Final Appraisal Report - Atazanavir (Reyataz) in treatment-naïve patients.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.Research output: Book/Report › Commissioned report
- Published
All Wales Medicines Strategy Group Final Appraisal Report - Buprenorphine/naloxone (Suboxone) as substitution treatment for opioid dependence.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.Research output: Book/Report › Commissioned report
- Published
All Wales Medicines Strategy Group Final Appraisal Report - Deferasirox (Exjade) for the treatment of chronic iron overload due to blood transfusions.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.Research output: Book/Report › Commissioned report
- Published
All Wales Medicines Strategy Group Final Appraisal Report - Docetaxel (Taxotere) for locally advanced squamous cell carcinoma of the head and neck.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.Research output: Book/Report › Commissioned report
- Published
All Wales Medicines Strategy Group Final Appraisal Report - Emtricitabine/tenofovir DF (Truvada)
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2007, 2007 ed. Unknown.Research output: Book/Report › Commissioned report
- Published
All Wales Medicines Strategy Group Final Appraisal Report - Epoetin delta (Dynepo)
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.Research output: Book/Report › Commissioned report